Life Sciences

FinTechs Made Personal Wealth Management Easier: Can MedTechs Do The Same For Personal Health?

The financial meltdown of 2007 did away with the image of banks as safe havens for wealth. A joint coup between emerging technologies and FinTech innovators triggered a change in how wealth was managed. The idea that an alternative to conventional banking models could exist suddenly seemed viable. FinTech brought a fresh approach to wealth 

Continue Reading…

Patient Engagement: The Catalyst to Care

In today’s value-based care environment, patient engagement is a vital key to success in clinical outcomes. This is especially true for chronic diseases such as arthritis, where continuous care is necessary because of the disease’s physical, emotional and economic impact on patients. Although the advent of specialty drugs in the past decade has made disease 

Continue Reading…

Only two future events are certain – death, and disruption of the status quo

Introducing “Redefining Innovation: Embracing The 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry” There is a crisis of innovation for incumbents in the biopharmaceutical industry that should concern all of us. Once innovators who were responsible for some of the most significant advances in medical care the human race has seen, these organizations have 

Continue Reading…

Pharma Companies, Escape the Black Hole of the conventional!

The pharmaceutical industry lives and breathes innovation, yet the nature of its products, and their direct relationship to human health necessitates the most conservative and methodical levels of control and oversight, to meet compliance, as driven by stringent regulations. Conventional safety frameworks, manually intensive processes and legacy systems create barriers to efficiency and innovation for 

Continue Reading…